glp-1 news insurers As struggle with drug costs, some seek to wean patients off GLP-1 drug coverage for obesity

There are two main incretin hormones in humans: GIP (glucose-dependent insulinotropic peptide

Other animal studies have found that GLP-1R agonists reduce amphetamine use and amphetamine-induced hyperlocomotion

Despite the FDA mandate, pharmacies have some legislative leeway based on dose and formulation tailoring, and certain companies are betting on this to stay active

Activating these receptors protects nerve cells from damage and calms inflammation in the brain, just as they do throughout the body

WHO (2025)

Substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), cardiometabolic disorders, chronic kidney disease, COPD, pneumonia, liver failure, inflammatory bowel disease, liver cancer) all significantly declined